index - Organisation de la cellule musculaire et thérapie de la myopathie centronucléaire autosomique dominante Accéder directement au contenu

Dernières publications

Chiffres clés

80 Publications avec texte intégral

Open Access

55 %

Mots clés

Disease modifiers Atrial cardiac defects Cell proliferation Domaine LEM Antisense oligonucleotides Autophagy cellular Amphiphysin Adeno-associated virus Cytoskeleton AFM Adhesion Dullard Alpha-actinin-2 BAF Clathrine Cancer Allele specific RNA interference Duchenne muscular dystrophy DMD Cross-presentation Autophagosome Actin nucleus AAV Muscle Correlative microscopy Allele‐specific silencing therapy Gene therapy DNM2 Dominant centronuclear myopathy Nuclear envelope Becker muscular dystrophy BMD Duchenne muscular dystrophy Animal models of human disease A-type lamins BAR proteins Developmental myosin heavy chain Cellules de crête neurale Clathrin Skeletal muscle Dynamine RNA interference Adeno-associated virus vector Actin Adult patients Cavéoles Autophagosome maturation ACTN2 CAV-3 gene Autophagy AD-CNM Cell migration Muscular dystrophy Dynamin overexpression Cross-bridge kinetics Congenital myopathy Cellular neuroscience BMP signaling Biomarkers Caveolin Caveolins Dystrophie musculaire de Duchenne Ctdnep1 Mechanotransduction Atrial heart defects Nesprin Allele-specific silencing therapy Biophysics Myopathie Endocytosis Migration DMyHC Centronuclear myopathy Cytosquelette Myosin Skin Cardiomyopathies Lamin Satellite cell Dynamin 2 Neural crest cells Duchenne Muscular Dystrophy Adeno-Associated virus Charcot-Marie-Tooth Diaphragm AAV8 Caveolae Developmental biology Dystrophie musculaire d'Emery Dreifuss Nucleus Cardiotoxin Cavins Outflow tract Myopathy Coeur Dynamin Core myopathy Disease heterogeneity Cell signaling Allele-specific silencing Autosomal dominant centronuclear myopathy CTL